N 343 2.5 (Glyburide 2.5 mg)
Pill with imprint N 343 2.5 is Orange, Round and has been identified as Glyburide 2.5 mg. It is supplied by Teva Pharmaceuticals USA.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for N 343 2.5
Glyburide
- Imprint:
- N 343 2.5
- Strength:
- 2.5 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- Inactive Ingredients:
- microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
silicon dioxide
magnesium stearate
FD&C Yellow No. 6
aluminum oxide
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0872 | UDL Laboratories Inc. |
| 42291-0316 | AvKare, Inc. |
| 35356-0360 | Lake Erie Medical and Surgical Supply (repackager) |
| 55289-0606 | PDRX Pharmaceuticals Inc. (repackager) |
More about glyburide
- Glyburide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 7 Reviews
- Drug class: sulfonylureas
Consumer resources
Other brands: DiaBeta, Micronase, Glynase, Glycron, Glynase PresTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
